Skip to content

Effectiveness of Ritalin, Stimedit and Practisa in primary school children with attention deficit hyperactivity disorder

Comparison of the effectiveness of Ritalin, Stimdate and Practisa in primary school children with Attention Deficit Hyperactivity Disorder

Status
Recruiting
Phases
Phase 2
Study type
Interventional
Source
IRCT
Registry ID
IRCT20160530028182N10
Enrollment
60
Registered
2023-09-20
Start date
2023-06-22
Completion date
Unknown
Last updated
2023-10-16

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Attention-Deficit Hyperactivity Disorder. Attention-deficit hyperactivity disorder, predominantly inattentive type

Interventions

Intervention 1: Intervention group: The patients included in the study during a period of 8 weeks are divided into three groups. The first group is Iranian methylphenidate (stimulant) 10 mg manufactur

Sponsors

Sanandaj University of Medical Sciences
Lead Sponsor

Eligibility

Sex/Gender
All
Age
6 Years to 12 Years

Inclusion criteria

Inclusion criteria: The age of these children is 6 to 12. Based on the diagnostic criteria of DSM-5, the child and adolescent psychiatry specialist should diagnose attention deficit hyperactivity disorder in children.

Exclusion criteria

Exclusion criteria: Existence of serious physical disease such as seizure disease, heart disease based on parents' history and clinical suspicion Presence of accompanying psychiatric disorder Mental retardation based on clinical suspicion Taking drugs for attention deficit hyperactivity disorder in the last month

Design outcomes

Primary

MeasureTime frame
Clinical Global Impressions Number. Timepoint: The beginning of the study (basic), 2 weeks, 4 weeks and 8 weeks after the study. Method of measurement: Clinical Global Impressions.

Countries

Iran (Islamic Republic of)

Contacts

Public ContactSoliman Mohammadzadeh

Sanandaj University of Medical Sciences

dr.mohammadzadeh86@muk.ac.ir+98 87 3366 4957

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 4, 2026